Monica Lynn Hollowell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Nodule | 8 | 2023 | 750 | 0.830 |
Why?
|
Thyroid Neoplasms | 9 | 2023 | 2282 | 0.590 |
Why?
|
Adenocarcinoma, Follicular | 4 | 2023 | 324 | 0.570 |
Why?
|
Odontogenic Tumors | 1 | 2010 | 45 | 0.360 |
Why?
|
Fibroma | 1 | 2010 | 212 | 0.320 |
Why?
|
Papilloma | 1 | 2007 | 148 | 0.280 |
Why?
|
Thyroid Gland | 4 | 2021 | 1173 | 0.250 |
Why?
|
Myofibromatosis | 1 | 2022 | 30 | 0.220 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2022 | 32 | 0.220 |
Why?
|
Hepatoblastoma | 1 | 2022 | 87 | 0.210 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2022 | 101 | 0.210 |
Why?
|
Uric Acid | 1 | 2008 | 766 | 0.210 |
Why?
|
Hashimoto Disease | 1 | 2022 | 97 | 0.200 |
Why?
|
Gynecomastia | 1 | 2022 | 88 | 0.200 |
Why?
|
Gout | 1 | 2008 | 573 | 0.190 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2021 | 83 | 0.190 |
Why?
|
Breast Neoplasms, Male | 1 | 2022 | 210 | 0.180 |
Why?
|
Protoporphyria, Erythropoietic | 1 | 2020 | 43 | 0.170 |
Why?
|
Cytodiagnosis | 2 | 2022 | 435 | 0.160 |
Why?
|
Thyroidectomy | 2 | 2021 | 879 | 0.160 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.160 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 281 | 0.140 |
Why?
|
Leiomyomatosis | 1 | 2016 | 70 | 0.130 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2020 | 365 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 694 | 0.130 |
Why?
|
Smooth Muscle Tumor | 1 | 2016 | 67 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2007 | 2020 | 0.130 |
Why?
|
Tuberculosis, Pleural | 1 | 2014 | 12 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 175 | 0.120 |
Why?
|
Balloon Occlusion | 1 | 2014 | 126 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.120 |
Why?
|
Eustachian Tube | 1 | 2014 | 91 | 0.120 |
Why?
|
Mastectomy | 1 | 2022 | 1793 | 0.110 |
Why?
|
Chondroma | 1 | 2013 | 58 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1363 | 0.110 |
Why?
|
Otologic Surgical Procedures | 1 | 2014 | 145 | 0.110 |
Why?
|
Ear Diseases | 1 | 2014 | 170 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 783 | 0.110 |
Why?
|
Epiphyses | 1 | 2013 | 189 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2455 | 0.110 |
Why?
|
Humerus | 1 | 2013 | 266 | 0.100 |
Why?
|
Sarcoma | 1 | 2022 | 1897 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 3 | 2022 | 1094 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.080 |
Why?
|
Diagnosis, Differential | 5 | 2022 | 12959 | 0.080 |
Why?
|
Child | 12 | 2023 | 77709 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2016 | 2969 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4253 | 0.070 |
Why?
|
Colchicine | 1 | 2008 | 243 | 0.070 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2007 | 102 | 0.070 |
Why?
|
Proteins | 1 | 2021 | 6103 | 0.070 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.060 |
Why?
|
Adolescent | 11 | 2023 | 85781 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Incidental Findings | 2 | 2022 | 689 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2022 | 37 | 0.060 |
Why?
|
Glypicans | 1 | 2022 | 34 | 0.050 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2021 | 13 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2022 | 224 | 0.050 |
Why?
|
Humans | 23 | 2023 | 744343 | 0.050 |
Why?
|
Ribonuclease III | 1 | 2023 | 275 | 0.050 |
Why?
|
Lip | 1 | 2022 | 195 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2529 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 1 | 2023 | 375 | 0.050 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Thyrotropin | 1 | 2022 | 849 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.040 |
Why?
|
Infant | 3 | 2022 | 35136 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 588 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13102 | 0.040 |
Why?
|
Rare Diseases | 1 | 2021 | 553 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3251 | 0.040 |
Why?
|
Female | 12 | 2022 | 380194 | 0.040 |
Why?
|
Male | 12 | 2022 | 350118 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6756 | 0.030 |
Why?
|
Cytogenetic Analysis | 1 | 2016 | 295 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.030 |
Why?
|
Child, Preschool | 4 | 2019 | 41006 | 0.030 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2035 | 0.030 |
Why?
|
Self-Examination | 1 | 2013 | 70 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56430 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2924 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20129 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1179 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
Leiomyoma | 1 | 2016 | 730 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3474 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6364 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1257 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4186 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2297 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Physical Examination | 1 | 2013 | 1237 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
Liver | 1 | 2022 | 7474 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1513 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 40561 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5256 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1832 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4851 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 213383 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 72290 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
Aged | 2 | 2016 | 163280 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81183 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53288 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 57776 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.000 |
Why?
|